MARKET

AZN

AZN

AstraZeneca
NYSE
188.41
+2.73
+1.47%
Pre Market: 188.57 +0.16 +0.08% 06:54 06/29 EDT
OPEN
184.28
PREV CLOSE
185.68
HIGH
189.57
LOW
184.28
VOLUME
1.72K
TURNOVER
35.66K
52 WEEK HIGH
210.50
52 WEEK LOW
132.81
MARKET CAP
292.23B
P/E (TTM)
28.32
1D
5D
1M
3M
1Y
5Y
1D
AstraZeneca notifies availability of announcement
PUBT · 36m ago
AstraZeneca announces Enhertu approval in EU for HER2 positive solid tumors
TipRanks · 1h ago
Weekly Report: what happened at AZN last week (0622-0626)?
Weekly Report · 1h ago
AstraZeneca says efzimfotase alfa meets primary endpoint in Phase 3 MULBERRY trial for pediatric hypophosphatasia
PUBT · 4h ago
AstraZeneca and Daiichi Sankyo win EU tumour‑agnostic approval for Enhertu
TipRanks · 4h ago
Daiichi Sankyo’s Enhertu wins EU approval for tumor-agnostic HER2+ metastatic solid tumors
PUBT · 4h ago
AstraZeneca’s Datroway Wins EU Backing for First-Line Triple-Negative Breast Cancer
TipRanks · 4h ago
AstraZeneca’s Datroway wins EU CHMP backing for first-line metastatic TNBC use
PUBT · 4h ago
More
About AZN
AstraZeneca PLC is a United Kingdom-based science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines. The Company operates across therapy areas, including Oncology; Cardiovascular, Renal and Metabolism (CVRM); Respiratory and Immunology (R&I); Vaccines and Immune Therapies (V&I), and Rare Disease. In the Oncology area, its key products include Tagrisso, Imfinzi, Calquence, Lynparza, and Enhertu. The key products of CVRM area include Farxiga/Forxiga, Brilinta/Brilique, Crestor, and Lokelma. In the R&I area, the key products are Symbicort, Fasenra, Breztri/Trixeo, and Tezspire. In the V&I Therapies area, the products are Beyfortus and FluMist. The products in the Rare Disease area are Ultomiris, Soliris, Strensiq, and Koselugo. It has about 191 projects in its development pipeline, including 19 new molecular entities (NMEs) in the late-stage pipeline. The Company distributes its products in over 125 countries.

Webull offers AstraZeneca PLC (US) stock information, including NYSE: AZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AZN stock methods without spending real money on the virtual paper trading platform.